Dose-dependent effectiveness and patient-reported outcomes with JAK1 inhibitors in atopic dermatitis: a 36-week multicenter real-world cohort
High-dose JAK1 regimens achieve faster, numerically greater disease control without short-term safety tradeoffs, supporting escalation in suboptimal responders.
Authors
- Gözde Ulutaş Demirbaş (ORCID: https://orcid.org/0000-0002-1468-4605)
- Mustafa Esen (ORCID: https://orcid.org/0000-0002-4736-9142)
- Abdullah Demirbaş (ORCID: https://orcid.org/0000-0002-3419-9084)
- Esin Diremsizoğlu (ORCID: https://orcid.org/0000-0001-9824-481X)
Institutions
- Dicle University (TR)
- Kocaeli Üniversitesi (TR)
Publication Details
- Journal
- Journal of Dermatological Treatment
- Published
- 2026-01-08
- DOI
- https://doi.org/10.1080/09546634.2025.2605834
- Citations
- 2
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 109.32